Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

SELL
$11.49 - $13.65 $257,732 - $306,183
-22,431 Reduced 3.6%
600,400 $7.34 Million
Q3 2022

Nov 04, 2022

SELL
$12.41 - $32.42 $21.6 Million - $56.4 Million
-1,741,070 Reduced 73.65%
622,831 $7.73 Million
Q2 2022

Jul 22, 2022

SELL
$19.63 - $26.62 $2.11 Million - $2.86 Million
-107,431 Reduced 4.35%
2,363,901 $46.4 Million
Q1 2022

May 04, 2022

SELL
$24.65 - $29.0 $1.72 Million - $2.02 Million
-69,713 Reduced 2.74%
2,471,332 $64.5 Million
Q4 2021

Jan 13, 2022

SELL
$27.74 - $34.09 $8.8 Million - $10.8 Million
-317,076 Reduced 11.09%
2,541,045 $72.1 Million
Q3 2021

Oct 27, 2021

BUY
$29.2 - $36.72 $11.8 Million - $14.9 Million
405,737 Added 16.54%
2,858,121 $91.1 Million
Q2 2021

Jul 15, 2021

BUY
$28.76 - $35.98 $70.5 Million - $88.2 Million
2,452,384 New
2,452,384 $85.1 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.